Optimizing the Workflow for Sensitive Detection of Bacteria and VirusesWebinarReplayIn 2019, a novel coronavirus (SARS‑CoV-2) was identified as the source of a pneumonia outbreak in Wuhan, China. The extraordinarily rapid spread of this disease, termed COVID-19, triggered numerous and urgent challenges to health systems, diagnostic laboratories and research communities throughout the world. Demand for reproducible and fast nucleic acid extraction has been unprecedented and as a result has become a limiting factor for COVID-19 detection globally. The most sensitive and reliable method of detection is the RT-PCR molecular swab test but one challenge that still remains is the need to increase the throughput of the RNA extraction step. Presented by:
Gabriel Fernandez de Pierola Gabriel Fernandez de Pierola is the Genomics & Diagnostic Solutions General Manager at Cytiva since 2017. He is responsible for the development and commercialization of products and services that enable automatable, cost-effective and reliable technologies focusing on genomics. Previously he was the Global Commercial Finance manager for the GE Healthcare Bioprocess business and holds a Bachelor of Business Administration degree from ICADE (Spain) and Reims Management School (France).
Dr. Chris Norey Dr. Chris Norey is an R&D Leader with over 25 years’ experience in the life sciences industry after gaining a PhD in Biochemistry and Molecular Biology. For the past 10 years Dr. Norey has lead teams responsible for launching over 25 new products, including instrumentation and reagent and consumable products. He currently leads the genomics R&D team at Cytiva focused on delivering tools for the growing field of genetic based diagnostic applications. |
|
Processing your request... |
